MIM
CMPX icon

Monashee Investment Management’s Compass Therapeutics CMPX Stock Holding History

Monashee Investment Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-258,865
Closed -$1.37M – 27
2026
Q1 		$1.37M Sell
258,865
-741,135
-74% -$4.28M 0.74% 37
2025
Q4 		$5.37M Sell
1,000,000
-250,000
-20% -$1.15M 3.03% 14
2025
Q3 		$4.38M Buy
1,250,000
+1,085,000
+658% +$3.43M 2.18% 17
2025
Q2 		$429K Sell
165,000
-283,164
-63% -$584K 0.16% 55
2025
Q1 		$852K Hold
448,164
– – 0.1% 46
2024
Q4 		$650K Sell
448,164
-51,836
-10% -$86.1K 0.09% 37
2024
Q3 		$920K Hold
500,000
– – 0.1% 98
2024
Q2 		$500K Hold
500,000
– – 0.06% 73
2024
Q1 		$990K Hold
500,000
– – 0.12% 90
2023
Q4 		$780K Sell
500,000
-726,142
-59% -$1.26M 0.14% 35
2023
Q3 		$2.42M Sell
1,226,142
-743,154
-38% -$1.84M 1.01% 37
2023
Q2 		$6.26M Sell
1,969,296
-207,746
-10% -$652K 1.49% 14
2023
Q1 		$7.12M Sell
2,177,042
-53,399
-2% -$210K 1.97% 10
2022
Q4 		$11.2M Buy
2,230,441
+1,000,000
+81% +$3.99M 4.83% 3
2022
Q3 		$2.81M Hold
1,230,441
– – 1.04% 14
2022
Q2 		$3.26M Sell
1,230,441
-39,770
-3% -$86.3K 1.19% 7
2022
Q1 		$1.74M Sell
1,270,211
-729,789
-36% -$1.51M 0.5% 21
2021
Q4 		$6.34M Buy
+2,000,000
New +$6.63M 1.57% 8

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Monashee Investment Management's CMPX Position: Q2 2026 in Review

Monashee Investment Management sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 258,865 shares — an estimated $1.37M sold.

Monashee Investment Management first reported a position in CMPX in Q4 2021 and held it in 18 quarters. The position peaked at $11.2M in Q4 2022. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Monashee Investment Management reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Monashee Investment Management sold 258,865 Compass Therapeutics shares in Q2 2026, an estimated $1.37M.
  • Monashee Investment Management first reported a position in Compass Therapeutics in Q4 2021 and held it in 18 quarters.
  • Monashee Investment Management's Compass Therapeutics position peaked at $11.2M in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.